We've merged with Palleos Healthcare to form a wide-reaching European CRO.
Find out more
Clinical Study Design Preparation
MedSci Consulting and Excellence™
Consulting and Regulatory Support
Drug Safety and Pharmacovigilance
Project Management and Monitoring
Clinical Data Management
Biostatistics for Clinical Studies
Clinical Supply Services and Logistics
Show All Services

Consulting and Regulatory Support

OCT boasts a 100% CTA approval rate across the countries where we operate: Latvia, Poland, Serbia, Georgia, Bulgaria, Ukraine, Lithuania, Moldova, Russia, the Netherlands and Spain.

Since 2005, we have been guiding our sponsors through the intricacies of the regulatory system both when dealing with national regulatory institutions and FDA or EMA. In addition to clinical trial approval, our goal is to help our clients develop and implement the most optimal registration strategy in order to speed up market access.

Operating in an environment with ever-evolving local and global regulatory platforms bears quite a few strategic, timeline and budget challenges. While these challenges cannot be disregarded or ignored, we do our best to make them manageable and contained. And being manageable means pursuing our clients’ best interests.

Natalya Eliseeva
Regulatory Manager

Specialized areas of expertise

• Document review as a part of preparation for a clinical trial application
 Development of the regulatory strategy
• CTA submission to the local regulatory authorities
 Obtaining of import/export permits for drug import and export of biological samples
 QP release for EU countries

Expertise in Central and Eastern Europe

Strong local expertise provided by our in-house regulatory and marketing authorization specialists, allows OCT Clinical to address a wide range of potential regulatory hurdles. 

Experience with FDA & EMA

In addition to the thorough knowledge of local regulatory specifics, we are proud of a solid track record in assisting our sponsors with global regulatory activities as follows:

• Successful experience in conducting pre-IND meetings with FDA
• Scientific advice meetings with EMA
• Submitting NDA applications to FDA
• Obtaining orphan drug status from EMA & FDA

Request a Callback

Why Our Clients Choose Us

Get in Touch with OCT Clinical

Thank you for your request!
Our team will respond to you within 24 hours.